BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAD3. A total of 19 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $2,444,000 | -53.3% | 685,000 | -59.7% | 0.01% | 0.0% |
| Q2 2014 | $5,228,000 | -37.7% | 1,700,000 | -31.7% | 0.01% | -68.4% |
| Q1 2014 | $8,390,000 | +0.9% | 2,490,000 | +4.2% | 0.02% | 0.0% |
| Q4 2013 | $8,317,000 | -35.1% | 2,390,000 | -33.0% | 0.02% | -36.7% |
| Q3 2013 | $12,816,000 | +117.0% | 3,565,000 | +67.4% | 0.03% | +114.3% |
| Q2 2013 | $5,907,000 | – | 2,130,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ANGELO GORDON & CO., L.P. | 7,047,000 | $24,506,000 | 1.92% |
| Baker Brothers Advisors | 22,898,000 | $79,367,000 | 1.12% |
| Amici Capital, LLC | 8,000,000 | $27,840,000 | 0.88% |
| RWC Asset Management LLP | 2,000,000 | $6,964,000 | 0.74% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $37,000 | 0.04% |
| CITIGROUP INC | 6,262,000 | $21,776,000 | 0.02% |
| LORD, ABBETT & CO. LLC | 2,390,000 | $8,317,000 | 0.02% |
| SG Americas Securities, LLC | 10,000 | $3,480,000 | 0.01% |
| DEUTSCHE BANK AG\ | 5,000,000 | $17,385,000 | 0.01% |
| SSI INVESTMENT MANAGEMENT LLC | 27,000 | $93,000 | 0.01% |